Psychedelic drug company Mind Medicine Inc. (MindMed) (NASDAQ: MNMD) published its 2025 Investor Presentation this week with more detail on its plans than the company’s 2024 presentation. The company was sitting on a generous cash cushion last year but has now added an additional $250 million equity investment to the…
Please login to read all 501 words.
